Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
34.8M
-
Shares change
-
+1.78M
-
Total reported value, excl. options
-
$1.46B
-
Value change
-
+$82.3M
-
Number of buys
-
58
-
Number of sells
-
-19
-
Price
-
$42.00
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q2 2020
84 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share as of Q2 2020.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.8M shares
of 75.6M outstanding shares and own 45.97% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.41M shares), Bain Capital Life Sciences Investors, LLC (7.28M shares), PERCEPTIVE ADVISORS LLC (3.51M shares), BVF INC/IL (2.29M shares), BOXER CAPITAL, LLC (2.08M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.23M shares), BlackRock Inc. (1.21M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (1.01M shares), CITADEL ADVISORS LLC (925K shares), and ArrowMark Colorado Holdings LLC (873K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.